CSRNP1 expression based on
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Comparison Statistical significance Normal-vs-Primary 1.83619999982731E-07
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Cancer stage information is not available for 3 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Stage1
3.176300E-02
Normal-vs-Stage2
2.56269999998615E-07
Normal-vs-Stage3
7.580800E-01
Normal-vs-Stage4
1.187160E-01
Stage1-vs-Stage2
7.325200E-01
Stage1-vs-Stage3
5.512200E-02
Stage1-vs-Stage4
3.505400E-01
Stage2-vs-Stage3
4.033200E-04
Stage2-vs-Stage4
1.841440E-01
Stage3-vs-Stage4
1.268250E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Patient race information is not available for 5 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Caucasian
1.57570000047791E-07
Normal-vs-AfricanAmerican
4.928400E-02
Normal-vs-Asian
2.268800E-01
Caucasian-vs-AfricanAmerican
5.142800E-01
Caucasian-vs-Asian
5.020600E-01
AfricanAmerican-vs-Asian
3.169400E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Patient gender information is not available for 1 sample.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Male
1.91800000000075E-05
Normal-vs-Female
9.72880000005283E-07
Male-vs-Female
1.797220E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Patient age information is not available for 1 sample.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Age(21-40Yrs)
5.702000E-02
Normal-vs-Age(41-60Yrs)
2.90650000001058E-06
Normal-vs-Age(61-80Yrs)
2.07029999998998E-05
Normal-vs-Age(81-100Yrs)
3.861400E-01
Age(21-40Yrs)-vs-Age(41-60Yrs)
3.169600E-01
Age(21-40Yrs)-vs-Age(61-80Yrs)
3.595700E-02
Age(21-40Yrs)-vs-Age(81-100Yrs)
1.608650E-01
Age(41-60Yrs)-vs-Age(61-80Yrs)
4.956100E-02
Age(41-60Yrs)-vs-Age(81-100Yrs)
2.120200E-01
Age(61-80Yrs)-vs-Age(81-100Yrs)
7.471200E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Drinking status is not available for 80 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Non Drinker
1.355730E-02
Normal-vs-Daily Drinker
5.157100E-03
Normal-vs-Weekly Drinker
9.939500E-02
Normal-vs-Occasional Drinker
2.296500E-02
Normal-vs-Social Drinker
2.156800E-01
Non Drinker-vs-Daily Drinker
4.358400E-01
Non Drinker-vs-Weekly Drinker
9.557000E-01
Non Drinker-vs-Occasional Drinker
5.609600E-01
Non Drinker-vs-Social Drinker
8.812600E-01
Daily Drinker-vs-Weekly Drinker
4.955800E-01
Daily Drinker-vs-Occasional Drinker
1.846390E-01
Daily Drinker-vs-Social Drinker
4.801000E-01
Weekly Drinker-vs-Occasional Drinker
7.012000E-01
Weekly Drinker-vs-Social Drinker
9.366200E-01
Occasional Drinker-vs-Social Drinker
8.255400E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma
Subtype descriptions Grade 1 Well differentiated (low grade)
Grade 2 Moderately differentiated (intermediate grade) Grade 3 Poorly differentiated (high grade)
Grade 4 Undifferentiated (high grade)
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Grade 1
4.903000E-01
Normal-vs-Grade 2
3.364400E-01
Normal-vs-Grade 3
4.408600E-01
Normal-vs-Grade 4
1.000000E+00
Grade 1-vs-Grade 2
5.975700E-02
Grade 1-vs-Grade 3
4.484000E-01
Grade 1-vs-Grade 4
4.903000E-01
Grade 2-vs-Grade 3
3.404000E-01
Grade 2-vs-Grade 4
3.364400E-01
Grade 3-vs-Grade 4
4.408600E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Diabetes status information is not available for 30 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Diabetic
2.756100E-03
Normal-vs-NonDiabetic
2.15140000003888E-06
Diabetic-vs-NonDiabetic
5.405600E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Pancreatitis status is not available for 39 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Pancreatitis
3.739400E-03
Normal-vs-NoPancreatitis
2.38450000000778E-06
Pancreatitis-vs-NoPancreatitis
6.793200E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Nodal metastais status is not available for 1 sample and cancer in nearby lymph nodes cannot be measured (NX) in 4 samples.
pathologic_N descriptions N0 No regional lymph node metastasis
N1 Metastases in 1 to 3 axillary lymph nodes N2 Metastases in 4 to 9 axillary lymph nodes
N3 Metastases in 10 or more axillary lymph nodes
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-N0
1.800400E-03
Normal-vs-N1
1.28279999955794E-07
N0-vs-N1
3.873400E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Whole exome sequencing data is not available for 3 samples.
TP53 mutation status is obtained from TCGA whole exome sequencing data. We downloaded Mutation Annotation Format (MAF) files (derived from VarScan2) from Genomic Data Commons portal. The sample with/without TP53 mutation were matched with RNA-seq data
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-TP53-Mutant
8.818200E-01
Normal-vs-TP53-NonMutant
8.541000E-01
TP53-Mutant-vs-TP53-NonMutant
2.512400E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
